Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Menarini Silicon Biosystems offers commercialized, FDA-cleared liquid biopsy solutions for detecting and analyzing circulating tumor cells in metastatic cancers. Their technologies enable non-invasive monitoring of disease progression and therapy response. The company also provides advanced tools for rare cell isolation/single-cell genomics supporting clinical research, drug development programs, and custom assay development. Their platforms have processed over 25,000 samples across nearly sixty clinical trials with more than twenty-five pharma partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Menarini Silicon Biosystems.